Zensar Technologies (504067) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
19 Jun, 2026Executive summary
Revenue for Q1 FY26 grew 3.3% sequentially to $162 million (₹13,850 million), up 4.9% YoY, with broad-based growth except for manufacturing and consumer services, which declined 4.1%.
Order book increased 11.7% YoY, with $172 million in new deals and strong AI-driven project momentum.
Attrition improved to 9.8% LTM, with salary hikes implemented as scheduled.
Net profit for Q1 FY26 was ₹1,820 million, and total comprehensive income reached ₹2,066 million.
Cash and investments totaled $315.7 million, up $25.2 million QoQ.
Financial highlights
EBITDA margin was 15.2%, down 40 bps QoQ due to higher sales, marketing, and travel expenses.
Gross profit margin stood at 30.5%, up 20 bps sequentially.
Profit before tax for Q1 FY26 was ₹2,406 million, up from ₹2,097 million YoY.
Basic EPS for the quarter was ₹8.01, compared to ₹6.96 in Q1 FY25.
Cash and investments at $315.7 million; FAD for the quarter was 13.1%.
Outlook and guidance
Management expects macro-driven variability in client budgets but projects growth in manufacturing and consumer services in Q2.
No double-digit growth guidance; focus remains on sequential quarterly growth and margin sustainability.
Salary hikes of $3 million and potential ESOP scheme to impact Q2 margins.
Continued focus on AI-driven digital transformation and ESG commitments, including net-zero emissions by FY45.
Board approved results on July 22, 2025, with ongoing emphasis on digital and cloud infrastructure growth.
Latest events from Zensar Technologies
- Q1 FY27 revenue up to $159.5M, EBITDA margin down, BFSI and AI drive growth, cash strong.504067
Q1 26/2730 Jul 2026 - Q3 FY25 revenue up 8.6% YoY to $157.0M, with 15.6% EBITDA margin and record order book.504067
Q3 24/259 Jul 2026 - Record order book and profit growth in FY26, with final dividend of ₹12.60 per share recommended.504067
Q4 25/268 Jul 2026 - Q4 FY25 saw 6.3% YoY revenue growth, higher PAT margin, strong order book, and increased dividends.504067
Q4 24/258 Jul 2026 - Record order book, stable margins, and strong BFSI/healthcare growth; BridgeView acquired.504067
Q2 24/2519 Jun 2026 - AI-driven growth, robust financials, and ESG leadership marked FY26 performance.504067
Investor presentation26 May 2026 - Q3 FY26 saw revenue and margin growth, strong order book, and continued AI-driven investments.504067
Q3 25/2623 Jan 2026 - Q2 revenue up 4.2% YoY to $162.8M, with margin gains, AI momentum, and TMT headwinds.504067
Q2 25/262 Nov 2025